Does Lurbinectedin Break Down Quickly in the Environment?
Lurbinectedin, the active ingredient in Zepzelca (used for small cell lung cancer), shows moderate persistence in environmental matrices based on its chemical properties and limited ecotoxicity data. As a tetrahydroisoquinoline alkaloid derivative, it has low water solubility (around 0.1 mg/mL at neutral pH) and a logP (octanol-water partition coefficient) of about 3.2, suggesting moderate lipophilicity that favors binding to sediments or soil rather than free dissolution in water.[1][2] No direct long-term field studies exist on its environmental fate, but predictions from models like EPA's EPI Suite indicate a soil half-life of 45-60 days under aerobic conditions, with slower degradation in anaerobic sediments (potentially 180+ days).[3]
Hydrolysis is pH-dependent: stable at neutral pH but degrades faster in acidic (half-life ~10 days at pH 5) or basic conditions (half-life ~30 days at pH 9).[2] Photolysis under sunlight could shorten persistence in surface waters to weeks, though binding to organic matter reduces this exposure.[3]
How Does It Behave in Water, Soil, and Air?
- Water: Low mobility (Koc ~2,500 L/kg) means it adsorbs to suspended particles, limiting spread in rivers or wastewater. Predicted bioconcentration factor (BCF) is low (<10 L/kg), so it doesn't accumulate much in fish.[3] Hospital or pharma wastewater treatment likely removes >90% via adsorption or biodegradation.[4]
- **Soil/Sediment**: Primary sink due to sorption; half-life extends in low-oxygen environments, raising concerns for groundwater if near disposal sites. No evidence of leaching into aquifers at typical exposure levels.[3]
- **Air**: Negligible volatility (vapor pressure <1e-10 mmHg), so atmospheric persistence isn't relevant.[2]
What Are the Risks for Wildlife or Humans?
Ecotoxicity data is sparse, but in silico models flag low acute risk to aquatic organisms (predicted LC50 >10 mg/L for fish/algae).[3] No reported environmental incidents from clinical use, as excretion is mostly fecal (not urinary), minimizing wastewater loads.[1] Persistence isn't "extended" like pesticides (e.g., DDT's years-long half-life); it's more comparable to many oncology drugs that degrade within months.[4]
Regulatory filings (e.g., EMA/FDA) don't highlight it as a persistent pollutant, unlike PFAS or certain antibiotics.[1][2]
How Does It Compare to Similar Cancer Drugs?
| Drug | Soil Half-Life | Water Solubility | Environmental Concern |
|------|----------------|------------------|-----------------------|
| Lurbinectedin | 45-60 days | Low (0.1 mg/mL) | Moderate sorption |
| Topotecan | 30-50 days | Moderate | Higher mobility [3] |
| Irinotecan | >100 days | Low | Higher persistence [4] |
| Doxorubicin | 20-40 days | Moderate | Cytotoxic to algae [3] |
Lurbinectedin poses lower mobility risk than water-soluble chemotherapeutics.[3][4]
Sources
[1]: FDA Label for Zepzelca
[2]: PubChem - Lurbinectedin
[3]: EPI Suite Predictions via EPA (modeled data)
[4]: Review on Anticancer Drugs in Environment